Therapeutic Asset Ratings
831 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
FLUTICASONE
Gastric Cancer
Mayo Clinic
P2
B
(58)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Castration-Resistant Prostate Carcinoma
Mayo Clinic
P2
B
(58)
Immunoglobulin G1 [de-C-terminal-lysine], anti-(human CC chemokine receptor CCR8) (human-Mus musculus monoclonal BMS-986340 ?1-chain), disulfide with human-Mus musculus monoclonal BMS-986340 ?-chain, dimer
Pancreatic Adenocarcinoma
Mayo Clinic
P2
B
(58)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine
Fallopian Tube Carcinosarcoma
Mayo Clinic
P2
B
(58)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine
Fallopian Tube Endometrioid Adenocarcinoma
Mayo Clinic
P2
B
(58)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine
Primary Peritoneal Carcinosarcoma
Mayo Clinic
P2
B
(58)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Fallopian Tube Clear Cell Adenocarcinoma
Mayo Clinic
P2
B
(58)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Fallopian Tube Endometrioid Adenocarcinoma
Mayo Clinic
P2
B
(58)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Ovarian Endometrioid Adenocarcinoma
Mayo Clinic
P2
B
(58)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Primary Peritoneal Serous Adenocarcinoma
Mayo Clinic
P2
B
(58)
Pembrolizumab
Fallopian Tube Carcinosarcoma
Mayo Clinic
P2
B
(58)
Pembrolizumab
IDH-Wildtype Glioblastoma
Mayo Clinic
P2
B
(58)
Pembrolizumab
Primary Peritoneal Carcinosarcoma
Mayo Clinic
P2
B
(58)
Relugolix
Castration-Resistant Prostate Carcinoma
Mayo Clinic
P2
B
(58)
TRASTUZUMAB
Castration-Resistant Prostate Carcinoma
Mayo Clinic
P2
B
(58)
VINCRISTINE SULFATE
Indolent B-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P2
B
(58)
Zofran
Recurrent Transformed Chronic Lymphocytic Leukemia
Mayo Clinic
P2
B
(58)
Hyaluronidase zzxf
Prostate Cancer
Mayo Clinic
P2
B
(57)
Midostaurin
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Mayo Clinic
P2
B
(57)
Nivolumab
Esophageal Squamous Cell Carcinoma
Mayo Clinic
P2
B
(57)
Rimegepant
Irritable Bowel Syndrome
Mayo Clinic
P2
B
(57)
Sargramostim
Gastric Cancer
Mayo Clinic
P2
B
(57)
Verteporfin
Malignant Pancreatic Neoplasm
Mayo Clinic
P2
B
(57)
FILGRASTIM
Locally Advanced Gastric Adenocarcinoma
Mayo Clinic
P1/2
B
(57)
FLUTICASONE
Locally Advanced Gastric Adenocarcinoma
Mayo Clinic
P1/2
B
(57)
Showing 251 to 275 of 831 assets
Previous
Page 11 of 34
Next
